Integra LifeSciences Holdings Corporation IART
Analyst Consensus
Price Objectif
Analyst historical
| Analyste | Entreprise | Prix lors de l'analyse | Prix cible | Gain potentiel | Date de publication |
|---|---|---|---|---|---|
| Ryan Zimmerman | BTIG | 17.43 $ | 20 $ | 2.57 % | 07/10/2024 |
| Richard Newitter | Truist Financial | 24.59 $ | 26 $ | 1.41 % | 30/07/2024 |
| Joanne Wuensch | Citigroup | 25.42 $ | 23 $ | -2.42 % | 30/07/2024 |
| Ryan Zimmerman | BTIG | 25.42 $ | 22 $ | -3.42 % | 29/07/2024 |
| Richard Newitter | Truist Financial | 29.84 $ | 32 $ | 2.16 % | 16/07/2024 |
| Richard Newitter | Truist Financial | 23.14 $ | 25 $ | 1.86 % | 07/05/2024 |
| David Turkaly | JMP Securities | 23.14 $ | 40 $ | 16.86 % | 07/05/2024 |
| Vik Chopra | Wells Fargo | 23.14 $ | 25 $ | 1.86 % | 06/05/2024 |
| Matt O'Brien | Piper Sandler | 46.85 $ | 50 $ | 3.15 % | 26/10/2022 |
| FY22 EPS | Piper Sandler | 56.53 $ | 55 $ | -1.53 % | 28/07/2022 |
| Anthony Petrone | Jefferies | 70.95 $ | 86 $ | 15.05 % | 20/05/2021 |
| Shagun Singh Chadha | RBC Capital | 75.07 $ | 74 $ | -1.07 % | 29/04/2021 |
| Larry Biegelsen | Wells Fargo | 75.07 $ | 74 $ | -1.07 % | 29/04/2021 |